Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
Kawasaki disease (KD) is rare in infants less than 3 months of age, and its recurrence is exceptional. Infants with KD are at higher risk of severe clinical presentation, therapy failure, complications and coronary aneurysms (CAAs), and this is the reason they deserve more aggressive therapy and a s...
Saved in:
Main Authors: | Grazia Bossi (Author), Alessia Claudia Codazzi (Author), Federica Vinci (Author), Edoardo Clerici (Author), Corrado Regalbuto (Author), Carmela Crapanzano (Author), Daniele Veraldi (Author), Alice Moiraghi (Author), Gian Luigi Marseglia (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications
by: Grazia Bossi, et al.
Published: (2023) -
Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
by: Alessandro Gambacorta, et al.
Published: (2020) -
Atipical kawasaki disease with coronary aneurysm in infant
by: Bandello Maria, et al.
Published: (2011) -
Intravenous administration of anakinra in children with macrophage activation syndrome
by: Omkar Phadke, et al.
Published: (2021) -
A child with resistant Kawasaki disease successfully treated with anakinra: a case report
by: J. Sánchez-Manubens, et al.
Published: (2017)